190 related articles for article (PubMed ID: 18387679)
1. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
Johnson MC; Damon IK; Karem KL
J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
[TBL] [Abstract][Full Text] [Related]
2. An improved plaque reduction virus neutralization assay for human metapneumovirus.
de Graaf M; Herfst S; Schrauwen EJ; van den Hoogen BG; Osterhaus AD; Fouchier RA
J Virol Methods; 2007 Aug; 143(2):169-74. PubMed ID: 17420056
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
[TBL] [Abstract][Full Text] [Related]
4. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
Borges MB; Kato SE; Damaso CR; Moussatché N; da Silva Freire M; Lambert Passos SR; do Nascimento JP
Biologicals; 2008 Mar; 36(2):105-10. PubMed ID: 17892944
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of human immunological responses to vaccinia virus.
Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
[TBL] [Abstract][Full Text] [Related]
6. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
[TBL] [Abstract][Full Text] [Related]
7. Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
Cosma A; Bühler S; Nagaraj R; Staib C; Hammarin AL; Wahren B; Goebel FD; Erfle V; Sutter G
Clin Diagn Lab Immunol; 2004 Mar; 11(2):406-10. PubMed ID: 15013995
[TBL] [Abstract][Full Text] [Related]
8. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
[TBL] [Abstract][Full Text] [Related]
9. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.
Earl PL; Americo JL; Moss B
J Virol; 2003 Oct; 77(19):10684-8. PubMed ID: 12970455
[TBL] [Abstract][Full Text] [Related]
10. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.
Eyal O; Olshevsky U; Lustig S; Paran N; Halevy M; Schneider P; Zomber G; Fuchs P
J Virol Methods; 2005 Dec; 130(1-2):15-21. PubMed ID: 16024096
[TBL] [Abstract][Full Text] [Related]
11. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
12. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
[TBL] [Abstract][Full Text] [Related]
13. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
Ferrier-Rembert A; Drillien R; Meignier B; Garin D; Crance JM
Vaccine; 2007 Nov; 25(49):8290-7. PubMed ID: 17964011
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.
Pastrana DV; Buck CB; Pang YY; Thompson CD; Castle PE; FitzGerald PC; Krüger Kjaer S; Lowy DR; Schiller JT
Virology; 2004 Apr; 321(2):205-16. PubMed ID: 15051381
[TBL] [Abstract][Full Text] [Related]
15. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
[TBL] [Abstract][Full Text] [Related]
16. Development of a new neutralization test for measles virus.
Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
[TBL] [Abstract][Full Text] [Related]
17. Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays.
Gates I; Olson V; Smith S; Patel N; Damon I; Karem K
PLoS One; 2015; 10(10):e0138836. PubMed ID: 26426117
[TBL] [Abstract][Full Text] [Related]
18. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein.
Khawplod P; Inoue K; Shoji Y; Wilde H; Ubol S; Nishizono A; Kurane I; Morimoto K
J Virol Methods; 2005 Apr; 125(1):35-40. PubMed ID: 15737414
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration.
Poirier B; Leparc-Goffart I; Crance JM; Fleury H; Garin D; Gut JP; Tissier MH; Fuchs F
Biologicals; 2005 Dec; 33(4):277-82. PubMed ID: 16181788
[TBL] [Abstract][Full Text] [Related]
20. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression.
Biacchesi S; Skiadopoulos MH; Yang L; Murphy BR; Collins PL; Buchholz UJ
J Virol Methods; 2005 Sep; 128(1-2):192-7. PubMed ID: 15955576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]